 | • レポートコード：B-GIR08C1079 • 出版社/出版日：GlobalInfoResearch / 2019年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：Medical Devices & Consumables |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、心臓バイオマーカー検査の世界市場について調べ、まとめました。種類別セグメントは、等、用途別セグメントは、等に区分しました。心臓バイオマーカー検査の世界市場概観、企業動向、企業別心臓バイオマーカー検査シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・心臓バイオマーカー検査の市場概観 ・心臓バイオマーカー検査の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・心臓バイオマーカー検査の企業別販売動向、市場シェア、市場集中度、競争動向 ・心臓バイオマーカー検査の世界市場規模 ・心臓バイオマーカー検査の北米市場分析（アメリカ、カナダ、メキシコ等） ・心臓バイオマーカー検査のアメリカ市場規模推移 ・心臓バイオマーカー検査のカナダ市場規模推移 ・心臓バイオマーカー検査のメキシコ市場規模推移 ・心臓バイオマーカー検査のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・心臓バイオマーカー検査のドイツ市場規模推移 ・心臓バイオマーカー検査のイギリス市場規模推移 ・心臓バイオマーカー検査のロシア市場規模推移 ・心臓バイオマーカー検査のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・心臓バイオマーカー検査の日本市場規模推移 ・心臓バイオマーカー検査の中国市場規模推移 ・心臓バイオマーカー検査の韓国市場規模推移 ・心臓バイオマーカー検査のインド市場規模推移 ・心臓バイオマーカー検査の東南アジア市場規模推移 ・心臓バイオマーカー検査の南米市場分析（ブラジル、アルゼンチン等） ・心臓バイオマーカー検査の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・心臓バイオマーカー検査の種類別分析/販売量、売上、市場シェア（） ・心臓バイオマーカー検査の用途別分析/市場規模（） ・心臓バイオマーカー検査の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・心臓バイオマーカー検査の販売チャネル・代理店・貿易業者・ディーラー分析 |
Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart.
Scope of the Report:
Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart. These biomarkers are used to diagnose heart functioning, risk stratifications, and cardiac diseases in patients. Biomarker is a quantifiable and measurable biological parameter that includes an enzyme, hormones, and proteins, all associated with heart function, failure, or damage.
The global Cardiac Biomarkers Testing market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Cardiac Biomarkers Testing.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Cardiac Biomarkers Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Cardiac Biomarkers Testing market by product type and applications/end industries.
Market Segment by Companies, this report covers
Abbott Laboratories
Becton, Dickinson and Company
BioMerieux
Bio-Rad Laboratories, Inc.
Danaher Corporation
F. HOFFMANN-LA ROCHE LTD.
Siemens AG
Thermo Fisher Scientific, Inc.
PerkinElmer Inc.
Tosoh Corporation
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Myocardial Muscle Creatine Kinase (CK-MB)
Troponins (T and I)
Myoglobin
Brain Natriuretic Peptide (BNPs) or NT-proBNP
Ischemia-modified Albumin (IMA)
Others
Market Segment by Applications, can be divided into
Myocardial Infarction
Congestive Heart Failure
Acute Coronary Syndrome
Atherosclerosis
Others
Table of Contents
1 Cardiac Biomarkers Testing Market Overview
1.1 Product Overview and Scope of Cardiac Biomarkers Testing
1.2 Classification of Cardiac Biomarkers Testing by Types
1.2.1 Global Cardiac Biomarkers Testing Revenue Comparison by Types (2019-2024)
1.2.2 Global Cardiac Biomarkers Testing Revenue Market Share by Types in 2018
1.2.3 Myocardial Muscle Creatine Kinase (CK-MB)
1.2.4 Troponins (T and I)
1.2.5 Myoglobin
1.2.6 Brain Natriuretic Peptide (BNPs) or NT-proBNP
1.2.7 Ischemia-modified Albumin (IMA)
1.2.8 Others
1.3 Global Cardiac Biomarkers Testing Market by Application
1.3.1 Global Cardiac Biomarkers Testing Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Myocardial Infarction
1.3.3 Congestive Heart Failure
1.3.4 Acute Coronary Syndrome
1.3.5 Atherosclerosis
1.3.6 Others
1.4 Global Cardiac Biomarkers Testing Market by Regions
1.4.1 Global Cardiac Biomarkers Testing Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Cardiac Biomarkers Testing Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Cardiac Biomarkers Testing Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cardiac Biomarkers Testing Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Cardiac Biomarkers Testing Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cardiac Biomarkers Testing Status and Prospect (2014-2024)
1.5 Global Market Size of Cardiac Biomarkers Testing (2014-2024)
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Business Overview
2.1.2 Cardiac Biomarkers Testing Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Laboratories Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
2.2 Becton, Dickinson and Company
2.2.1 Business Overview
2.2.2 Cardiac Biomarkers Testing Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Becton, Dickinson and Company Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
2.3 BioMerieux
2.3.1 Business Overview
2.3.2 Cardiac Biomarkers Testing Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 BioMerieux Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
2.4 Bio-Rad Laboratories, Inc.
2.4.1 Business Overview
2.4.2 Cardiac Biomarkers Testing Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bio-Rad Laboratories, Inc. Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
2.5 Danaher Corporation
2.5.1 Business Overview
2.5.2 Cardiac Biomarkers Testing Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Danaher Corporation Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
2.6 F. HOFFMANN-LA ROCHE LTD.
2.6.1 Business Overview
2.6.2 Cardiac Biomarkers Testing Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 F. HOFFMANN-LA ROCHE LTD. Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
2.7 Siemens AG
2.7.1 Business Overview
2.7.2 Cardiac Biomarkers Testing Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Siemens AG Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
2.8 Thermo Fisher Scientific, Inc.
2.8.1 Business Overview
2.8.2 Cardiac Biomarkers Testing Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Thermo Fisher Scientific, Inc. Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
2.9 PerkinElmer Inc.
2.9.1 Business Overview
2.9.2 Cardiac Biomarkers Testing Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 PerkinElmer Inc. Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
2.10 Tosoh Corporation
2.10.1 Business Overview
2.10.2 Cardiac Biomarkers Testing Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Tosoh Corporation Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
3 Global Cardiac Biomarkers Testing Market Competition, by Players
3.1 Global Cardiac Biomarkers Testing Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Cardiac Biomarkers Testing Players Market Share
3.2.2 Top 10 Cardiac Biomarkers Testing Players Market Share
3.3 Market Competition Trend
4 Global Cardiac Biomarkers Testing Market Size by Regions
4.1 Global Cardiac Biomarkers Testing Revenue and Market Share by Regions
4.2 North America Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
4.3 Europe Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
4.5 South America Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
5 North America Cardiac Biomarkers Testing Revenue by Countries
5.1 North America Cardiac Biomarkers Testing Revenue by Countries (2014-2019)
5.2 USA Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
5.3 Canada Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
5.4 Mexico Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
6 Europe Cardiac Biomarkers Testing Revenue by Countries
6.1 Europe Cardiac Biomarkers Testing Revenue by Countries (2014-2019)
6.2 Germany Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
6.3 UK Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
6.4 France Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
6.5 Russia Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
6.6 Italy Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Cardiac Biomarkers Testing Revenue by Countries
7.1 Asia-Pacific Cardiac Biomarkers Testing Revenue by Countries (2014-2019)
7.2 China Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
7.3 Japan Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
7.4 Korea Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
7.5 India Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
8 South America Cardiac Biomarkers Testing Revenue by Countries
8.1 South America Cardiac Biomarkers Testing Revenue by Countries (2014-2019)
8.2 Brazil Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
8.3 Argentina Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
8.4 Colombia Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Cardiac Biomarkers Testing by Countries
9.1 Middle East and Africa Cardiac Biomarkers Testing Revenue by Countries (2014-2019)
9.2 Saudi Arabia Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
9.3 UAE Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
9.4 Egypt Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
9.5 Nigeria Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
9.6 South Africa Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
10 Global Cardiac Biomarkers Testing Market Segment by Type
10.1 Global Cardiac Biomarkers Testing Revenue and Market Share by Type (2014-2019)
10.2 Global Cardiac Biomarkers Testing Market Forecast by Type (2019-2024)
10.3 Myocardial Muscle Creatine Kinase (CK-MB) Revenue Growth Rate (2014-2024)
10.4 Troponins (T and I) Revenue Growth Rate (2014-2024)
10.5 Myoglobin Revenue Growth Rate (2014-2024)
10.6 Brain Natriuretic Peptide (BNPs) or NT-proBNP Revenue Growth Rate (2014-2024)
10.7 Ischemia-modified Albumin (IMA) Revenue Growth Rate (2014-2024)
10.8 Others Revenue Growth Rate (2014-2024)
11 Global Cardiac Biomarkers Testing Market Segment by Application
11.1 Global Cardiac Biomarkers Testing Revenue Market Share by Application (2014-2019)
11.2 Cardiac Biomarkers Testing Market Forecast by Application (2019-2024)
11.3 Myocardial Infarction Revenue Growth (2014-2019)
11.4 Congestive Heart Failure Revenue Growth (2014-2019)
11.5 Acute Coronary Syndrome Revenue Growth (2014-2019)
11.6 Atherosclerosis Revenue Growth (2014-2019)
11.7 Others Revenue Growth (2014-2019)
12 Global Cardiac Biomarkers Testing Market Size Forecast (2019-2024)
12.1 Global Cardiac Biomarkers Testing Market Size Forecast (2019-2024)
12.2 Global Cardiac Biomarkers Testing Market Forecast by Regions (2019-2024)
12.3 North America Cardiac Biomarkers Testing Revenue Market Forecast (2019-2024)
12.4 Europe Cardiac Biomarkers Testing Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Cardiac Biomarkers Testing Revenue Market Forecast (2019-2024)
12.6 South America Cardiac Biomarkers Testing Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Cardiac Biomarkers Testing Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Cardiac Biomarkers Testing Picture
Table Product Specifications of Cardiac Biomarkers Testing
Table Global Cardiac Biomarkers Testing and Revenue (Million USD) Market Split by Product Type
Figure Global Cardiac Biomarkers Testing Revenue Market Share by Types in 2018
Figure Myocardial Muscle Creatine Kinase (CK-MB) Picture
Figure Troponins (T and I) Picture
Figure Myoglobin Picture
Figure Brain Natriuretic Peptide (BNPs) or NT-proBNP Picture
Figure Ischemia-modified Albumin (IMA) Picture
Figure Others Picture
Table Global Cardiac Biomarkers Testing Revenue (Million USD) by Application (2014-2024)
Figure Cardiac Biomarkers Testing Revenue Market Share by Applications in 2018
Figure Myocardial Infarction Picture
Figure Congestive Heart Failure Picture
Figure Acute Coronary Syndrome Picture
Figure Atherosclerosis Picture
Figure Others Picture
Table Global Market Cardiac Biomarkers Testing Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Cardiac Biomarkers Testing Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Cardiac Biomarkers Testing Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Cardiac Biomarkers Testing Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Cardiac Biomarkers Testing Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Cardiac Biomarkers Testing Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Cardiac Biomarkers Testing Revenue (Million USD) and Growth Rate (2014-2024)
Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table Abbott Laboratories Cardiac Biomarkers Testing Type and Applications
Table Abbott Laboratories Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
Table Becton, Dickinson and Company Basic Information, Manufacturing Base and Competitors
Table Becton, Dickinson and Company Cardiac Biomarkers Testing Type and Applications
Table Becton, Dickinson and Company Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
Table BioMerieux Basic Information, Manufacturing Base and Competitors
Table BioMerieux Cardiac Biomarkers Testing Type and Applications
Table BioMerieux Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
Table Bio-Rad Laboratories, Inc. Basic Information, Manufacturing Base and Competitors
Table Bio-Rad Laboratories, Inc. Cardiac Biomarkers Testing Type and Applications
Table Bio-Rad Laboratories, Inc. Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
Table Danaher Corporation Basic Information, Manufacturing Base and Competitors
Table Danaher Corporation Cardiac Biomarkers Testing Type and Applications
Table Danaher Corporation Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
Table F. HOFFMANN-LA ROCHE LTD. Basic Information, Manufacturing Base and Competitors
Table F. HOFFMANN-LA ROCHE LTD. Cardiac Biomarkers Testing Type and Applications
Table F. HOFFMANN-LA ROCHE LTD. Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
Table Siemens AG Basic Information, Manufacturing Base and Competitors
Table Siemens AG Cardiac Biomarkers Testing Type and Applications
Table Siemens AG Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
Table Thermo Fisher Scientific, Inc. Basic Information, Manufacturing Base and Competitors
Table Thermo Fisher Scientific, Inc. Cardiac Biomarkers Testing Type and Applications
Table Thermo Fisher Scientific, Inc. Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
Table PerkinElmer Inc. Basic Information, Manufacturing Base and Competitors
Table PerkinElmer Inc. Cardiac Biomarkers Testing Type and Applications
Table PerkinElmer Inc. Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
Table Tosoh Corporation Basic Information, Manufacturing Base and Competitors
Table Tosoh Corporation Cardiac Biomarkers Testing Type and Applications
Table Tosoh Corporation Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
Table Global Cardiac Biomarkers Testing Revenue (Million USD) by Players (2014-2019)
Table Global Cardiac Biomarkers Testing Revenue Share by Players (2014-2019)
Figure Global Cardiac Biomarkers Testing Revenue Share by Players in 2017
Figure Global Cardiac Biomarkers Testing Revenue Share by Players in 2018
Figure Global Top 5 Players Cardiac Biomarkers Testing Revenue Market Share in 2018
Figure Global Top 10 Players Cardiac Biomarkers Testing Revenue Market Share in 2018
Figure Global Cardiac Biomarkers Testing Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Cardiac Biomarkers Testing Revenue (Million USD) by Regions (2014-2019)
Table Global Cardiac Biomarkers Testing Revenue Market Share by Regions (2014-2019)
Figure Global Cardiac Biomarkers Testing Revenue Market Share by Regions (2014-2019)
Figure Global Cardiac Biomarkers Testing Revenue Market Share by Regions in 2018
Figure North America Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
Figure Europe Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
Figure South America Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
Table North America Cardiac Biomarkers Testing Revenue by Countries (2014-2019)
Table North America Cardiac Biomarkers Testing Revenue Market Share by Countries (2014-2019)
Figure North America Cardiac Biomarkers Testing Revenue Market Share by Countries (2014-2019)
Figure North America Cardiac Biomarkers Testing Revenue Market Share by Countries in 2018
Figure USA Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
Figure Canada Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
Figure Mexico Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
Table Europe Cardiac Biomarkers Testing Revenue (Million USD) by Countries (2014-2019)
Figure Europe Cardiac Biomarkers Testing Revenue Market Share by Countries (2014-2019)
Figure Europe Cardiac Biomarkers Testing Revenue Market Share by Countries in 2018
Figure Germany Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
Figure UK Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
Figure France Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
Figure Russia Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
Figure Italy Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Cardiac Biomarkers Testing Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Cardiac Biomarkers Testing Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Cardiac Biomarkers Testing Revenue Market Share by Countries in 2018
Figure China Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
Figure Japan Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
Figure Korea Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
Figure India Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
Table South America Cardiac Biomarkers Testing Revenue by Countries (2014-2019)
Table South America Cardiac Biomarkers Testing Revenue Market Share by Countries (2014-2019)
Figure South America Cardiac Biomarkers Testing Revenue Market Share by Countries (2014-2019)
Figure South America Cardiac Biomarkers Testing Revenue Market Share by Countries in 2018
Figure Brazil Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
Figure Argentina Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
Figure Colombia Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Cardiac Biomarkers Testing Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Cardiac Biomarkers Testing Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Cardiac Biomarkers Testing Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Cardiac Biomarkers Testing Revenue Market Share by Countries in 2018
Figure Saudi Arabia Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
Figure UAE Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
Figure Egypt Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
Figure Nigeria Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
Figure South Africa Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
Table Global Cardiac Biomarkers Testing Revenue (Million USD) by Type (2014-2019)
Table Global Cardiac Biomarkers Testing Revenue Share by Type (2014-2019)
Figure Global Cardiac Biomarkers Testing Revenue Share by Type (2014-2019)
Figure Global Cardiac Biomarkers Testing Revenue Share by Type in 2018
Table Global Cardiac Biomarkers Testing Revenue Forecast by Type (2019-2024)
Figure Global Cardiac Biomarkers Testing Market Share Forecast by Type (2019-2024)
Figure Global Myocardial Muscle Creatine Kinase (CK-MB) Revenue Growth Rate (2014-2019)
Figure Global Troponins (T and I) Revenue Growth Rate (2014-2019)
Figure Global Myoglobin Revenue Growth Rate (2014-2019)
Figure Global Brain Natriuretic Peptide (BNPs) or NT-proBNP Revenue Growth Rate (2014-2019)
Figure Global Ischemia-modified Albumin (IMA) Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Table Global Cardiac Biomarkers Testing Revenue by Application (2014-2019)
Table Global Cardiac Biomarkers Testing Revenue Share by Application (2014-2019)
Figure Global Cardiac Biomarkers Testing Revenue Share by Application (2014-2019)
Figure Global Cardiac Biomarkers Testing Revenue Share by Application in 2018
Table Global Cardiac Biomarkers Testing Revenue Forecast by Application (2019-2024)
Figure Global Cardiac Biomarkers Testing Market Share Forecast by Application (2019-2024)
Figure Global Myocardial Infarction Revenue Growth Rate (2014-2019)
Figure Global Congestive Heart Failure Revenue Growth Rate (2014-2019)
Figure Global Acute Coronary Syndrome Revenue Growth Rate (2014-2019)
Figure Global Atherosclerosis Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Cardiac Biomarkers Testing Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Cardiac Biomarkers Testing Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Cardiac Biomarkers Testing Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Cardiac Biomarkers Testing Revenue Market Forecast (2019-2024)
Figure Europe Cardiac Biomarkers Testing Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Cardiac Biomarkers Testing Revenue Market Forecast (2019-2024)
Figure South America Cardiac Biomarkers Testing Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Cardiac Biomarkers Testing Revenue Market Forecast (2019-2024)
心臓マーカー診断検査の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Cardiac Marker Diagnostic Testing market is valued at million USD in 2018 and is expected to reach million USD by the end of 2024, growing at a CAGR of between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, a…- EPOバイオマーカー市場：世界及び中国の市場分析・予測（～2024年） EPO Biomarkers Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global EPO Biomarkers industry with a focus on the Chinese market. The report provides key statistics on the market status of the EPO Biomarkers manufacturers and is a va…
- 世界のEPOバイオマーカー市場：市場規模・現状・予測 Erythropoietin (EPO) is a hormone that is produced from the kidney inside the human body. EPO biomarkers are used to increase the growth of red blood cells in the body by stimulating the bone marrow.Major factors contributing to the growth of the global EPO biomarkers market include increasing seden…
- 血清バイオマーカー市場：世界及び中国の市場分析・予測（～2024年） Serum Biomarkers Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Serum Biomarkers industry with a focus on the Chinese market. The report provides key statistics on the market status of the Serum Biomarkers manufacturers and i…
- 世界の腎臓バイオマーカー市場：市場規模・現状・予測 Renal biomarkers help diagnose or identify the patients at risk of developing kidney diseases, by measuring their blood or urine levels. They are commonly released in acute or chronic kidney injuries, which are characterized by the rapid or gradual loss of kidney function resulting into serous clini…